salinomycin; salinomycinum (Coxistac)
Jump to navigation
Jump to search
Indications
- treatment of breast cancer (possibly)
Laboratory
Mechanism of action
- selectively toxic to breast cancer stem cells
More general terms
References
- ↑ Gupta PB et al Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009 Aug 21; 138:645 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19682730 <Internet> http://dx.doi.org/10.1016/j.cell.2009.06.034
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=72370
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6473797
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3085092
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5151
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=23686751
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11072689
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6602499
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6602450
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6602450